{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T22:44:02Z","timestamp":1773355442695,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18pc0101026"],"award-info":[{"award-number":["JP18pc0101026"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.xops.2025.100965","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:43:23Z","timestamp":1760075003000},"page":"100965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety and Efficacy of Orally Administered SJP-0008 in Central Retinal Artery Occlusion: A Phase IIa Randomized Clinical Trial"],"prefix":"10.1016","volume":"6","author":[{"given":"Satoru","family":"Tsuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0642-793X","authenticated-orcid":false,"given":"Hiroshi","family":"Kunikata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshifumi","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azusa","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhide","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8810-4944","authenticated-orcid":false,"given":"Masayuki","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5591-4155","authenticated-orcid":false,"given":"Toru","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2025.100965_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ajo.2019.01.009","article-title":"Acute vascular ischemic events in patients with central retinal artery occlusion in the United States: a nationwide study 2003-2014","volume":"200","author":"Mir","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100965_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282003","article-title":"Exploratory clinical trial to evaluate the efficacy and safety of transdermal electrical stimulation in patients with central retinal artery occlusion","volume":"18","author":"Miura","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.xops.2025.100965_bib3","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/eye.2013.25","article-title":"A review of central retinal artery occlusion: clinical presentation and management","volume":"27","author":"Varma","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2025.100965_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-041104","article-title":"Nationwide incidence of central retinal artery occlusion in Japan: an exploratory descriptive study using the National Database of Health Insurance Claims (2011-2015)","volume":"10","author":"Kido","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.xops.2025.100965_bib5","series-title":"StatPearls [Internet]","article-title":"Central retinal artery occlusion","author":"Tripathy","year":"2024"},{"key":"10.1016\/j.xops.2025.100965_bib6","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jamaneurol.2015.1578","article-title":"Intravenous fibrinolytic therapy in central retinal artery occlusion a patient-level meta-analysis","volume":"72","author":"Schrag","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.xops.2025.100965_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ajo.2024.09.027","article-title":"Outcomes of hyperbaric oxygen treatment for central retinal artery occlusion: a single center experience","volume":"269","author":"Kim","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100965_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229068","article-title":"Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: an open-label, non-randomized, first-inhumans, phase 1\/2 trial","volume":"15","author":"Ikeda","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.xops.2025.100965_bib12","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1136\/bjo.2006.097642","article-title":"Surgical embolus removal in retinal artery occlusion","volume":"90","author":"Garc\u00eda-Arum\u00ed","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100965_bib13","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ophtha.2010.03.061","article-title":"Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial","volume":"117","author":"Schumacher","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100965_bib14","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s11064-021-03521-9","article-title":"Calpain inhibitors as potential therapeutic modulators in neurodegenerative diseases","volume":"47","author":"Khan","year":"2022","journal-title":"Neurochem Res"},{"key":"10.1016\/j.xops.2025.100965_bib15","series-title":"Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects","article-title":"Potential use of calpain inhibitors as brain injury therapy","author":"Cagmat","year":"2015"},{"key":"10.1016\/j.xops.2025.100965_bib16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2174\/138161206775474314","article-title":"Calpain inhibition: a therapeutic strategy targeting multiple disease states","volume":"12","author":"Carragher","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.xops.2025.100965_bib17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.survophthal.2007.12.006","article-title":"The role of calcium-activated protease calpain in experimental retinal pathology","volume":"53","author":"Azuma","year":"2008","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.xops.2025.100965_bib18","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1167\/iovs.11-7497","article-title":"Calpain, not caspase, is the causative protease for hypoxic damage in cultured monkey retinal cells","volume":"52","author":"Nakajima","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100965_bib19","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1016\/j.bmc.2005.04.059","article-title":"Exploration of orally available calpain inhibitors: peptidyl \u03b1-ketoamides containing an amphiphile at P3 site","volume":"13","author":"Shirasaki","year":"2005","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.xops.2025.100965_bib20","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1089\/jop.2013.0100","article-title":"Degeneration and dysfunction of retinal neurons in acute ocular hypertensive rats: involvement of calpains","volume":"30","author":"Suzuki","year":"2014","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.xops.2025.100965_bib21","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1167\/iovs.15-17360","article-title":"Hypoxia activates calpains in the nerve fiber layer of monkey retinal explants","volume":"56","author":"Hirata","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100965_bib22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1089\/jop.2006.22.417","article-title":"Retinal penetration of calpain inhibitors in rats after oral administration","volume":"22","author":"Shirasaki","year":"2006","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.xops.2025.100965_bib23","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/jnr.22800","article-title":"Critical role of calpain in axonal damage-induced retinal ganglion cell death","volume":"90","author":"Ryu","year":"2012","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.xops.2025.100965_bib24","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.ophtha.2014.04.029","article-title":"Nationwide incidence of clinically diagnosed central retinal artery occlusion in Korea, 2008 to 2011","volume":"121","author":"Park","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100965_bib25","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ajo.2011.05.005","article-title":"The incidence of central retinal artery occlusion in Olmsted County, Minnesota","volume":"152","author":"Leavitt","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100965_bib27","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.2147\/OPTH.S327704","article-title":"Population-based incidence of ocular neovascularization following central retinal artery occlusion in Olmsted County, Minnesota","volume":"15","author":"Tanke","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.xops.2025.100965_bib28","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/S0161-6420(88)33042-3","article-title":"Iris neovascularization associated with obstruction of the central retinal artery","volume":"95","author":"Duker","year":"1988","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100965_bib29","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/112067211002000603","article-title":"Ocular neovascularization following central retinal artery occlusion: prevalence and timing of onset","volume":"20","author":"Rudkin","year":"2010","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100965_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ajo.2024.10.004","article-title":"Multimodal imaging characteristics and correlation to outcomes in patients with central retinal artery occlusion presenting to a large academic center","volume":"270","author":"Hoyek","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100965_bib31","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0014-4835(03)00214-8","article-title":"Central retinal artery occlusion. Retinal survival time","volume":"78","author":"Hayreh","year":"2004","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.xops.2025.100965_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198114","article-title":"Intravenous thrombolysis in acute central retinal artery occlusion \u2013 a prospective interventional case series","volume":"13","author":"Schultheiss","year":"2018","journal-title":"PLoS One"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914525002635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914525002635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T11:55:48Z","timestamp":1773316548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914525002635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2666914525002635"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2025.100965","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and Efficacy of Orally Administered SJP-0008 in Central Retinal Artery Occlusion: A Phase IIa Randomized Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2025.100965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100965"}}